Terminal Lucidity, EBV and MS, and Why TV Watching Shrinks Your Brain

Brain health and dementia prevention are central concerns for anyone focused on longevity, and this week's neurology roundup from MedPage Today delivers several findings worth paying close attention to.

One of the most discussed items is terminal lucidity — the unexplained phenomenon where dementia patients briefly recover cognitive abilities just before death. While not yet fully understood mechanistically, it raises important questions about what residual brain function persists even in advanced neurodegeneration, and what that might mean for future therapies.

On the lifestyle front, frequent television watching was associated with increased white matter hyperintensity volume and reduced brain volumes in frontal, occipital, and Alzheimer's disease-signature regions in longitudinal data. This is a meaningful signal: white matter hyperintensities are markers of small vessel disease and cognitive decline risk. Sedentary screen time may be a modifiable brain-aging accelerant worth limiting.

For those tracking infectious disease and neurological risk, researchers pinpointed specific Epstein-Barr virus components linked to multiple sclerosis development, adding mechanistic detail to the growing EBV-MS hypothesis. This could eventually inform preventive strategies, including vaccines. Separately, early-onset dementia was associated with reduced work productivity up to 15 years before diagnosis in a Finnish study, suggesting subclinical cognitive decline manifests in functional ways long before clinical recognition.

The roundup also notes that people with essential tremor face elevated rates of mild cognitive impairment and dementia compared to the general population — a finding with implications for monitoring and early intervention. Interleukin-6 receptor blockers showed low relapse rates in myelin oligodendrocyte glycoprotein antibody-associated disease, though occasional severe infections were flagged.

Caveats apply throughout: several findings come from retrospective or observational studies, limiting causal conclusions. Readers should consult primary sources for effect sizes and study design details before drawing firm clinical conclusions.